The data that emerged from multivariate analysis suggest that high systemic level of IL-8, but not IL-6, is associated with ESCC progression, despite the fact that IL-6 was highly significant for poor overall survival estimate by Kaplan–Meier analysis (Table 3). The gene discussed is IL6; the disease is esophageal squamous cell carcinoma.